Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0040034|thrombocytopenia |
Sentences | 3 |
PubMedID- 23336236 | [low-dose rituximab regimen in 7 patients with immune thrombocytopenia secondary to connective tissue disease]. |
PubMedID- 24260074 | This regimen is contraindicated in patients with thrombocytopenia and the inconvenience often results in low compliance (11). |
PubMedID- 21339260 | This treatment regimen is often associated with significant lymphopenia, thrombocytopenia, and progressive blood-brain barrier dysfunction that can result in clinical and radiologic deterioration without true tumor progression ("pseudoprogression"). |
Page: 1